Found: 10
Select item for more details and to access through your institution.
Population-specific genetic modification of Huntington's disease in Venezuela.
- Published in:
- PLoS Genetics, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.pgen.1007274
- By:
- Publication type:
- Article
Protein Tyrosine Phosphatases PTP-1B, SHP-2, and PTEN Facilitate Rb/E2F-Associated Apoptotic Signaling.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097104
- By:
- Publication type:
- Article
Docosahexaenoic Acid Inhibits UVB-Induced Activation of NF-κB and Expression of COX-2 and NOX-4 in HR-1 Hairless Mouse Skin by Blocking MSK1 Signaling.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0028065
- By:
- Publication type:
- Article
Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.89782
- By:
- Publication type:
- Article
cis-9,trans-11-Conjugated linoleic acid down-regulates phorbol ester-induced NF-κB activation and subsequent COX-2 expression in hairless mouse skin by targeting IκB kinase and PI3K-Akt.
- Published in:
- Carcinogenesis, 2007, v. 28, n. 2, p. 363
- By:
- Publication type:
- Article
Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 2, p. 359
- By:
- Publication type:
- Article
Ultraviolet B radiation activates NF-κB and induces iNOS expression in HR-1 hairless mouse skin: Role of IκB kinase-β.
- Published in:
- Molecular Carcinogenesis, 2011, v. 50, n. 4, p. 310, doi. 10.1002/mc.20646
- By:
- Publication type:
- Article
Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
- Published in:
- Human Molecular Genetics, 2017, v. 26, n. 7, p. 1258, doi. 10.1093/hmg/ddx033
- By:
- Publication type:
- Article
Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 20, p. 4566, doi. 10.1093/hmg/ddw286
- By:
- Publication type:
- Article
The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756285617741837
- By:
- Publication type:
- Article